AT350559B - Verfahren zur herstellung von neuen 5-(1,1- diphenyl-3-(5- oder 6-hydroxy-2-azabicyclo (2,2,2)-oct-2-yl)propyl)-2-alkyl-1,3,4-oxa- diazolen - Google Patents

Verfahren zur herstellung von neuen 5-(1,1- diphenyl-3-(5- oder 6-hydroxy-2-azabicyclo (2,2,2)-oct-2-yl)propyl)-2-alkyl-1,3,4-oxa- diazolen

Info

Publication number
AT350559B
AT350559B AT157477A AT157477A AT350559B AT 350559 B AT350559 B AT 350559B AT 157477 A AT157477 A AT 157477A AT 157477 A AT157477 A AT 157477A AT 350559 B AT350559 B AT 350559B
Authority
AT
Austria
Prior art keywords
oxadiazoles
azabicyclo
diphenyl
oct
propyl
Prior art date
Application number
AT157477A
Other languages
German (de)
English (en)
Other versions
ATA157477A (de
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ATA157477A publication Critical patent/ATA157477A/de
Application granted granted Critical
Publication of AT350559B publication Critical patent/AT350559B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT157477A 1976-03-10 1977-03-09 Verfahren zur herstellung von neuen 5-(1,1- diphenyl-3-(5- oder 6-hydroxy-2-azabicyclo (2,2,2)-oct-2-yl)propyl)-2-alkyl-1,3,4-oxa- diazolen AT350559B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/665,609 US4013668A (en) 1976-03-10 1976-03-10 5-(1,1-diphenyl-3-(5- or 6-hydroxy-2-azabicyclo(2.2.2)oct-2-yl)propyl)-2-alkyl-1,3,4-oxadiazoles and related compounds

Publications (2)

Publication Number Publication Date
ATA157477A ATA157477A (de) 1978-11-15
AT350559B true AT350559B (de) 1979-06-11

Family

ID=24670819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT157477A AT350559B (de) 1976-03-10 1977-03-09 Verfahren zur herstellung von neuen 5-(1,1- diphenyl-3-(5- oder 6-hydroxy-2-azabicyclo (2,2,2)-oct-2-yl)propyl)-2-alkyl-1,3,4-oxa- diazolen

Country Status (17)

Country Link
US (1) US4013668A (enExample)
JP (1) JPS5951955B2 (enExample)
AT (1) AT350559B (enExample)
AU (1) AU505650B2 (enExample)
BE (1) BE852252A (enExample)
CA (1) CA1078386A (enExample)
CH (1) CH627467A5 (enExample)
DE (1) DE2710242A1 (enExample)
DK (1) DK103777A (enExample)
ES (1) ES456687A1 (enExample)
FR (1) FR2343740A2 (enExample)
GB (1) GB1524653A (enExample)
IE (1) IE44639B1 (enExample)
NL (1) NL7702537A (enExample)
NZ (1) NZ183540A (enExample)
SE (1) SE7702640L (enExample)
ZA (1) ZA771428B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0241180A (ja) * 1988-07-29 1990-02-09 Shinji Kanda 耐火避難用カプセル
DE69220258T2 (de) * 1991-02-11 1997-12-18 Merck Sharp & Dohme Azabicyclische Verbindungen, diese enthaltende pharmazeutische Zubereitungen und ihre therapeutische Verwendung
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
US6353004B1 (en) 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
PT1615646E (pt) * 2003-04-08 2015-02-12 Progenics Pharm Inc Formulações farmacêuticas com metilnaltrexona
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
PT2565195E (pt) * 2007-03-29 2015-07-28 Wyeth Llc Antagonistas e receptor opióide periférico e respectivas utilizações
PE20130480A1 (es) 2007-03-29 2013-05-08 Progenics Pharm Inc Compuestos heterociclicos como antagonistas del receptor opioide periferico
MX2009010550A (es) * 2007-03-29 2009-12-14 Progenics Pharm Inc Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
CA2713568C (en) 2008-02-06 2016-09-20 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
WO2010029313A1 (en) * 2008-09-11 2010-03-18 Summit Corporation Plc. Antiinfective compounds
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917615A (en) * 1974-04-01 1975-11-04 Searle & Co 1,1-Diaryl-1-oxadiazol-alkylamines

Also Published As

Publication number Publication date
DK103777A (da) 1977-09-11
FR2343740A2 (fr) 1977-10-07
CA1078386A (en) 1980-05-27
US4013668A (en) 1977-03-22
IE44639B1 (en) 1982-02-10
JPS5951955B2 (ja) 1984-12-17
IE44639L (en) 1977-09-10
NZ183540A (en) 1980-05-27
ZA771428B (en) 1978-10-25
GB1524653A (en) 1978-09-13
ES456687A1 (es) 1978-02-01
SE7702640L (sv) 1977-09-11
CH627467A5 (de) 1982-01-15
JPS52108999A (en) 1977-09-12
AU2302977A (en) 1978-09-14
FR2343740B2 (enExample) 1980-06-20
ATA157477A (de) 1978-11-15
NL7702537A (nl) 1977-09-13
AU505650B2 (en) 1979-11-29
DE2710242A1 (de) 1977-09-22
BE852252A (fr) 1977-09-09

Similar Documents

Publication Publication Date Title
AT350559B (de) Verfahren zur herstellung von neuen 5-(1,1- diphenyl-3-(5- oder 6-hydroxy-2-azabicyclo (2,2,2)-oct-2-yl)propyl)-2-alkyl-1,3,4-oxa- diazolen
AT357529B (de) Verfahren zur herstellung von neuen 5-(subst. phenyl)-oxazolidinonen und deren schwefel- analoga
AT376212B (de) Verfahren zur herstellung von neuen 1,2,4-triazolderivaten
AT360663B (de) Verfahren zur herstellung von neuen 6,7- -benzomorphanen
AT342045B (de) Verfahren zur herstellung von neuen 1,1-diaryl-1-oxadiazolalkylaminen
ATA518080A (de) Verfahren zur herstellung von neuen 3",4"diacyltylosinderivaten
AT354434B (de) Verfahren zur herstellung von neuen 1,4- diphenyl-3-pyrazolin-5-onen
ATA151379A (de) Verfahren zur herstellung von neuen 9alpha,21- dihalogen-11beta,17alpha-dihydroxy-6alpha-fluor -16beta-methyl-pregna-1,4-dien-verbindungen
AT341540B (de) Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen
AT372681B (de) Verfahren zur herstellung von neuen 1,5-disubstituierter hydantoinen
AT360529B (de) Verfahren zur herstellung von neuen 1,2,3- triazolderivaten
ATA759979A (de) Verfahren zur herstellung von neuen bis(2,5-diaminophenoxy)-aklanen
AT360037B (de) Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT355575B (de) Verfahren zur herstellung von neuen 1- (azacyclischen aralkoxyphenyl)-2- oder -3-(bis -arylalkylamino)-alkanen
AT353989B (de) Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden
DD132497A1 (de) Verfahren zur herstellung von neuen gona-4,9(10)-dienen
AT341669B (de) Verfahren zur herstellung von neuen 3,4-dicarboxycephalosporinen
AT373269B (de) Verfahren zur herstellung von neuen 3,20-dioxo-7 alpha-halogen-4-pregnenen und -1,4-pregnadienen
AT356125B (de) Verfahren zur herstellung von neuen 1-aryloxy- -2,3-epoxypropanen
AT367758B (de) Verfahren zur herstellung von neuen 20-methyl-13, 14-didehydro-pgi 2-derivaten
ATA272280A (de) Verfahren zur herstellung von neuen 1,4dihydropyridinverbindungen
ATA36277A (de) Verfahren zur herstellung von neuen 3,5,5-tris- -indolyl-2-(5h)-furanonen
AT361940B (de) Verfahren zur herstellung von neuen n,n'-thio- -bis-oximcarbamaten
AT377267B (de) Verfahren zur herstellung von neuen 3,20-dioxo7alpha-halogen-4-pregnenen und -1,4-pregnadienen
ATA790079A (de) Verfahren zur herstellung von neuen 5-substituierten benzo(c)-chinolinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties